22NW, LP holds a concentrated book of 16 stocks worth $145.9M as of Q1 2026 (disclosed May 15, 2026, a ~45-day 13F lag). This quarter they opened Fox Factory Holding Corp and trimmed Foster (LB) Co-A. Their largest long position is Foster (LB) Co-A at 20% of the equity book. Cloning the disclosed picks since 2017 would be +798% (+26.2%/yr). That is a simulation of the disclosed long book, not audited returns.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1694297/holdings"
Use Arkolith to show 22NW, LP's latest holdings, largest changes, and filing provenance.
Following at the filing date actually beat the quarter-end book by 214.2 points over this window.
Growth of $10,000 cloning 22NW, LP's disclosed long 13F book, rebalanced on each filing date (so it reflects the ~45-day reporting lag, no look-ahead), total-return basis (dividends reinvested), derived from end-of-day prices. “Their reported book” values the same picks from quarter-end, before they were public. S&P 500 is SPY total return over the same window. Excludes shorts, cash, options and non-13F holdings. Not investment advice.
Top-heavy: concentrated book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
97% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Other tracked managers holding the same core names as 22NW, LP
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| VANGUARD GROUP INC | 19 / 16 | $523.0M |
| MORGAN STANLEY | 18 / 16 | $137.7M |
| BlackRock, Inc. | 17 / 16 | $589.1M |
| STATE STREET CORP | 17 / 16 | $216.5M |
| GEODE CAPITAL MANAGEMENT, LLC | 17 / 16 | $149.5M |
| UBS Group AG | 17 / 16 | $58.4M |
| NORTHERN TRUST CORP | 17 / 16 | $51.1M |
| VANGUARD FIDUCIARY TRUST CO | 17 / 16 | $47.1M |
Ranked by how many of 22NW, LP's top 16 disclosed names each fund also holds: a cross-fund conviction signal from the latest 13F of every tracked manager.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Foster L B Co COM | $29.8M | 1.07M | 20.4% | ▼−10% Reduced · −124K sh | |
| 2 | Nektar Therapeutics COM NEW | $20.2M | 281.1K | 13.9% | ▼−15% Reduced · −50K sh | |
| 3 | Lifecore Biomedical Inc COM | $18.9M | 1.3K | 12.9% | —Held | |
| 4 | Insperity Inc COM | $13.3M | 493.0K | 9.1% | ▲+412% Added · +397K sh | |
| 5 | Mineralys Therapeutics Inc COM | $12.0M | 444.3K | 8.2% | ▲+24% Added · +86K sh | |
| 6 | Stoneridge Inc COM | $11.9M | 2.47M | 8.2% | ▲+13% Added · +274K sh | |
| 7 | Fox Factory Hldg Corp COM | $11.2M | 678.2K | 7.7% | ▲New New position | |
| 8 | Culp Inc COM | $5.1M | 1.86M | 3.5% | —Held | |
| 9 | Core Molding Technologies In COM | $5.0M | 222.7K | 3.4% | —Held | |
| 10 | Regenxbio Inc COM | $4.1M | 492.8K | 2.8% | ▼−47% Reduced · −431K sh | |
| 11 | Unifi Inc COM NEW | $3.0M | 852.5K | 2.1% | —Held | |
| 12 | Team Inc COM NEW | $2.7M | 170.2K | 1.9% | —Held | |
| 13 | Rezolute Inc COM NEW | $2.5M | 820.7K | 1.7% | —Held | |
| 14 | Farmer Bros Co COM | $2.5M | 1.96M | 1.7% | —Held | |
| 15 | Eledon Pharmaceuticals Inc COM | $2.0M | 636.4K | 1.3% | —Held | |
| 16 | Phenixfin Corp COM | $1.7M | 43.1K | 1.2% | ▼−63% Reduced · −75K sh |
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q1 2026 | Mar 31, 2026 | May 15, 2026 | 16 | $145.9M | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 13, 2026 | 20 | $237.6M | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 14, 2025 | 21 | $212.3M | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 14, 2025 | 21 | $158.8M | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 14, 2025 | 20 | $149.1M | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 14, 2025 | 16 | $158.5M | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 14, 2024 | 13 | $119.3M | 13F-HR |
| Q2 2024 | Jun 30, 2024 | Aug 14, 2024 | 13 | $117.2M | 13F-HR |
| Q1 2024 | Mar 31, 2024 | May 15, 2024 | 13 | $116.1M | 13F-HR |
| Q4 2023 | Dec 31, 2023 | Feb 14, 2024 | 14 | $153.5M | 13F-HR |
| Q3 2023 | Sep 30, 2023 | Nov 14, 2023 | 14 | $140.3M | 13F-HR |
| Q2 2023 | Jun 30, 2023 | Aug 14, 2023 | 14 | $160.1M | 13F-HR |
| Q1 2023 | Mar 31, 2023 | May 15, 2023 | 17 | $162.7M | 13F-HR |
| Q4 2022 | Dec 31, 2022 | Feb 10, 2023 | 19 | $185.2M | 13F-HR |
| Q3 2022 | Sep 30, 2022 | Nov 14, 2022 | 20 | $176.8M | 13F-HR |
| Q2 2022 | Jun 30, 2022 | Aug 12, 2022 | 20 | $188.4M | 13F-HR |
| Q1 2022 | Mar 31, 2022 | May 13, 2022 | 25 | $275.4M | 13F-HR |
| Q4 2021 | Dec 31, 2021 | Feb 14, 2022 | 25 | $323.4M | 13F-HR |
| Q3 2021 | Sep 30, 2021 | Nov 12, 2021 | 28 | $335.7M | 13F-HR |
| Q2 2021 | Jun 30, 2021 | Aug 16, 2021 | 34 | $372.1M | 13F-HR |
| Q1 2021 | Mar 31, 2021 | May 14, 2021 | 36 | $324.6M | 13F-HR |
| Q4 2020 | Dec 31, 2020 | Feb 12, 2021 | 35 | $279.3M | 13F-HR |
| Q3 2020 | Sep 30, 2020 | Nov 13, 2020 | 39 | $197.2M | 13F-HR |
| Q2 2020 | Jun 30, 2020 | Aug 14, 2020 | 63 | $184.4M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.